메뉴 건너뛰기




Volumn 8, Issue FEB, 2017, Pages

High kynurenine (a tryptophan metabolite) predicts remission in patients with major depression to add-on treatment with celecoxib

Author keywords

Celecoxib; Cyclooxygenase 2; Depression; Kynurenines; Remission

Indexed keywords

CELECOXIB; KYNURENIC ACID; KYNURENINE; QUINOLINIC ACID; REBOXETINE; TRYPTOPHAN;

EID: 85014220465     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2017.00016     Document Type: Article
Times cited : (39)

References (32)
  • 1
    • 0027981293 scopus 로고
    • Cytokines in major depression
    • Maes M. Cytokines in major depression. Biol Psychiatry (1994) 36(7):498-9. doi: 10.1016/0006-3223(94)90652-1
    • (1994) Biol Psychiatry , vol.36 , Issue.7 , pp. 498-499
    • Maes, M.1
  • 2
    • 0026473129 scopus 로고
    • Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio
    • Maes M, Stevens W, DeClerck L, Bridts C, Peeters D, Schotte C, et al. Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand (1992) 86(6):423-31. doi:10.1111/j.1600-0447.1992.tb03292.x
    • (1992) Acta Psychiatr Scand , vol.86 , Issue.6 , pp. 423-431
    • Maes, M.1    Stevens, W.2    DeClerck, L.3    Bridts, C.4    Peeters, D.5    Schotte, C.6
  • 3
    • 0027295619 scopus 로고
    • Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis
    • Muller N, Hofschuster E, Ackenheil M, Mempel W, Eckstein R. Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry (1993) 17(5):713-30. doi:10.1016/0278-5846(93)90055-W
    • (1993) Prog Neuropsychopharmacol Biol Psychiatry , vol.17 , Issue.5 , pp. 713-730
    • Muller, N.1    Hofschuster, E.2    Ackenheil, M.3    Mempel, W.4    Eckstein, R.5
  • 4
    • 24644433745 scopus 로고    scopus 로고
    • Th1, Th2, and Th3 cytokine alterations in major depression
    • Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord (2005) 88(2):167-73. doi:10.1016/j.jad.2005.07.008
    • (2005) J Affect Disord , vol.88 , Issue.2 , pp. 167-173
    • Myint, A.M.1    Leonard, B.E.2    Steinbusch, H.W.3    Kim, Y.K.4
  • 6
    • 84893345725 scopus 로고    scopus 로고
    • Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder
    • Carvalho LA, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk WJ, Birkenhager TK, et al. Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry (2014) 4:e344. doi:10.1038/tp.2013.118
    • (2014) Transl Psychiatry , vol.4
    • Carvalho, L.A.1    Bergink, V.2    Sumaski, L.3    Wijkhuijs, J.4    Hoogendijk, W.J.5    Birkenhager, T.K.6
  • 8
    • 84940609837 scopus 로고    scopus 로고
    • Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder
    • Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimaki M. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav Immun (2015) 49:206-15. doi:10.1016/j.bbi.2015.06.001
    • (2015) Brain Behav Immun , vol.49 , pp. 206-215
    • Haapakoski, R.1    Mathieu, J.2    Ebmeier, K.P.3    Alenius, H.4    Kivimaki, M.5
  • 9
    • 65649152524 scopus 로고    scopus 로고
    • Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis
    • Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med (2009) 71(2):171-86. doi:10.1097/PSY.0b013e3181907c1b
    • (2009) Psychosom Med , vol.71 , Issue.2 , pp. 171-186
    • Howren, M.B.1    Lamkin, D.M.2    Suls, J.3
  • 10
    • 0031971507 scopus 로고    scopus 로고
    • The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
    • Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord (1998) 49(3):211-9. doi:10.1016/S0165-0327(98)00025-1
    • (1998) J Affect Disord , vol.49 , Issue.3 , pp. 211-219
    • Song, C.1    Lin, A.2    Bonaccorso, S.3    Heide, C.4    Verkerk, R.5    Kenis, G.6
  • 13
    • 0024520842 scopus 로고
    • Salivary prostaglandin concentrations: possible state indicators for major depression
    • Nishino S, Ueno R, Ohishi K, Sakai T, Hayaishi O. Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry (1989) 146(3):365-8. doi:10.1176/ajp.146.3.365
    • (1989) Am J Psychiatry , vol.146 , Issue.3 , pp. 365-368
    • Nishino, S.1    Ueno, R.2    Ohishi, K.3    Sakai, T.4    Hayaishi, O.5
  • 14
    • 0023867453 scopus 로고
    • Increased level of salivary prostaglandins in patients with major depression
    • Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O. Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry (1988) 23(4):326-34. doi:10.1016/0006-3223(88)90283-1
    • (1988) Biol Psychiatry , vol.23 , Issue.4 , pp. 326-334
    • Ohishi, K.1    Ueno, R.2    Nishino, S.3    Sakai, T.4    Hayaishi, O.5
  • 15
    • 67650083320 scopus 로고    scopus 로고
    • Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
    • Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety (2009) 26(7):607-11. doi:10.1002/da.20589
    • (2009) Depress Anxiety , vol.26 , Issue.7 , pp. 607-611
    • Akhondzadeh, S.1    Jafari, S.2    Raisi, F.3    Nasehi, A.A.4    Ghoreishi, A.5    Salehi, B.6
  • 16
    • 33745617042 scopus 로고    scopus 로고
    • The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
    • Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 11(7):680-4. doi:10.1038/sj.mp.4001805
    • (2006) Mol Psychiatry , vol.11 , Issue.7 , pp. 680-684
    • Muller, N.1    Schwarz, M.J.2    Dehning, S.3    Douhe, A.4    Cerovecki, A.5    Goldstein-Muller, B.6
  • 17
    • 84885788151 scopus 로고    scopus 로고
    • Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis
    • Na KS, Lee KJ, Lee JS, Cho YS, Jung HY. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2014) 48:79-85. doi:10.1016/j.pnpbp.2013.09.006
    • (2014) Prog Neuropsychopharmacol Biol Psychiatry , vol.48 , pp. 79-85
    • Na, K.S.1    Lee, K.J.2    Lee, J.S.3    Cho, Y.S.4    Jung, H.Y.5
  • 18
    • 0033975012 scopus 로고    scopus 로고
    • Cytokine production and treatment response in major depressive disorder
    • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 22(4):370-9. doi:10.1016/s0893-133x(99)00134-7
    • (2000) Neuropsychopharmacology , vol.22 , Issue.4 , pp. 370-379
    • Lanquillon, S.1    Krieg, J.C.2    Bening-Abu-Shach, U.3    Vedder, H.4
  • 19
    • 33845213789 scopus 로고    scopus 로고
    • Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy
    • O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2007) 41(3-4):326-31. doi:10.1016/j.jpsychires.2006.05.013
    • (2007) J Psychiatr Res , vol.41 , Issue.3-4 , pp. 326-331
    • O'Brien, S.M.1    Scully, P.2    Fitzgerald, P.3    Scott, L.V.4    Dinan, T.G.5
  • 20
    • 84929104982 scopus 로고    scopus 로고
    • Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy
    • Grosse L, Carvalho LA, Birkenhager TK, Hoogendijk WJ, Kushner SA, Drexhage HA, et al. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology (Berl) (2016) 233(9):1679-88. doi:10.1007/s00213-015-3943-9
    • (2016) Psychopharmacology (Berl) , vol.233 , Issue.9 , pp. 1679-1688
    • Grosse, L.1    Carvalho, L.A.2    Birkenhager, T.K.3    Hoogendijk, W.J.4    Kushner, S.A.5    Drexhage, H.A.6
  • 22
    • 34547794475 scopus 로고    scopus 로고
    • The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
    • Muller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry (2007) 12(11):988-1000. doi:10.1038/sj.mp.4002006
    • (2007) Mol Psychiatry , vol.12 , Issue.11 , pp. 988-1000
    • Muller, N.1    Schwarz, M.J.2
  • 23
    • 0242720163 scopus 로고    scopus 로고
    • Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression
    • Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses (2003) 61(5-6):519-25. doi:10.1016/S0306-9877(03)00207-X
    • (2003) Med Hypotheses , vol.61 , Issue.5-6 , pp. 519-525
    • Myint, A.M.1    Kim, Y.K.2
  • 24
    • 33846018443 scopus 로고    scopus 로고
    • Kynurenine pathway in major depression: evidence of impaired neuroprotection
    • Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord (2007) 98(1-2):143-51. doi:10.1016/j.jad.2006.07.013
    • (2007) J Affect Disord , vol.98 , Issue.1-2 , pp. 143-151
    • Myint, A.M.1    Kim, Y.K.2    Verkerk, R.3    Scharpe, S.4    Steinbusch, H.5    Leonard, B.6
  • 25
    • 0021716040 scopus 로고
    • The alteration of membrane proteins in human erythrocyte membranes induced by quinolinic acid, an endogenous neurotoxin. Correlation of effect with structure
    • Farmer BT II, Nicholas MM, Butterfield DA. The alteration of membrane proteins in human erythrocyte membranes induced by quinolinic acid, an endogenous neurotoxin. Correlation of effect with structure. Biochim Biophys Acta (1984) 778(2):260-8. doi:10.1016/0005-2736(84)90367-5
    • (1984) Biochim Biophys Acta , vol.778 , Issue.2 , pp. 260-268
    • Farmer, B.T.1    Nicholas, M.M.2    Butterfield, D.A.3
  • 26
    • 0019967973 scopus 로고
    • An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid
    • Perkins MN, Stone TW. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 247(1):184-7. doi:10.1016/0006-8993(82)91048-4
    • (1982) Brain Res , vol.247 , Issue.1 , pp. 184-187
    • Perkins, M.N.1    Stone, T.W.2
  • 27
    • 77953194779 scopus 로고    scopus 로고
    • Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
    • Oades RD, Myint AM, Dauvermann MR, Schimmelmann BG, Schwarz MJ. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behav Brain Funct (2010) 6:32. doi:10.1186/1744-9081-6-32
    • (2010) Behav Brain Funct , vol.6 , pp. 32
    • Oades, R.D.1    Myint, A.M.2    Dauvermann, M.R.3    Schimmelmann, B.G.4    Schwarz, M.J.5
  • 28
    • 0033006124 scopus 로고    scopus 로고
    • Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis
    • Morrison PF, Morishige GM, Beagles KE, Heyes MP. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis. J Neurochem (1999) 72(5):2135-44. doi:10.1046/j.1471-4159.1999.0722135.x
    • (1999) J Neurochem , vol.72 , Issue.5 , pp. 2135-2144
    • Morrison, P.F.1    Morishige, G.M.2    Beagles, K.E.3    Heyes, M.P.4
  • 29
    • 0020702374 scopus 로고
    • Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain
    • Schwarcz R, Whetsell WO Jr, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 219(4582):316-8. doi:10.1126/science.6849138
    • (1983) Science , vol.219 , Issue.4582 , pp. 316-318
    • Schwarcz, R.1    Whetsell, W.O.2    Mangano, R.M.3
  • 30
    • 81155157520 scopus 로고    scopus 로고
    • Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
    • Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation (2011) 8:94. doi:10.1186/1742-2094-8-94
    • (2011) J Neuroinflammation , vol.8 , pp. 94
    • Steiner, J.1    Walter, M.2    Gos, T.3    Guillemin, G.J.4    Bernstein, H.G.5    Sarnyai, Z.6
  • 31
    • 84867582069 scopus 로고    scopus 로고
    • Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study
    • Abbasi SH, Hosseini F, Modabbernia A, AshrafiM, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord (2012) 141(2-3):308-14. doi:10.1016/j.jad.2012.03.033
    • (2012) J Affect Disord , vol.141 , Issue.2-3 , pp. 308-314
    • Abbasi, S.H.1    Hosseini, F.2    Modabbernia, A.3    Ashrafi, M.4    Akhondzadeh, S.5
  • 32
    • 21244495606 scopus 로고    scopus 로고
    • IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity
    • Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry (2005) 10(6):538-44. doi:10.1038/sj.mp.4001600
    • (2005) Mol Psychiatry , vol.10 , Issue.6 , pp. 538-544
    • Wichers, M.C.1    Koek, G.H.2    Robaeys, G.3    Verkerk, R.4    Scharpe, S.5    Maes, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.